Heather M. Judge

1.8k total citations
41 papers, 1.3k citations indexed

About

Heather M. Judge is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Heather M. Judge has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cardiology and Cardiovascular Medicine, 15 papers in Surgery and 14 papers in Internal Medicine. Recurrent topics in Heather M. Judge's work include Antiplatelet Therapy and Cardiovascular Diseases (36 papers), Venous Thromboembolism Diagnosis and Management (14 papers) and Acute Myocardial Infarction Research (12 papers). Heather M. Judge is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (36 papers), Venous Thromboembolism Diagnosis and Management (14 papers) and Acute Myocardial Infarction Research (12 papers). Heather M. Judge collaborates with scholars based in United Kingdom, United States and France. Heather M. Judge's co-authors include Robert F. Storey, Robert Buckland, Joseph A. Jakubowski, Robert A. Wilcox, Stan Heptinstall, Mark R. Thomas, Ian Sabroe, Atsuhiro Sugidachi, Sheila Francis and Gary Peters and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and International Journal of Molecular Sciences.

In The Last Decade

Heather M. Judge

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heather M. Judge United Kingdom 22 887 351 335 326 131 41 1.3k
Marsha L. Fox United States 14 888 1.0× 320 0.9× 403 1.2× 307 0.9× 108 0.8× 20 1.3k
Sandra Penz Germany 8 518 0.6× 236 0.7× 397 1.2× 200 0.6× 65 0.5× 11 915
Kenji Misumi Japan 13 499 0.6× 123 0.4× 263 0.8× 235 0.7× 177 1.4× 20 1.0k
DaLi Feng United States 17 623 0.7× 133 0.4× 289 0.9× 171 0.5× 45 0.3× 27 1.0k
Carmen H. Tong United States 15 236 0.3× 181 0.5× 250 0.7× 323 1.0× 70 0.5× 32 1.1k
Mariateresa Pugliano Italy 12 361 0.4× 181 0.5× 464 1.4× 123 0.4× 57 0.4× 22 868
Stefania Momi Italy 18 283 0.3× 135 0.4× 316 0.9× 182 0.6× 137 1.0× 25 957
Keiji Takazoe Japan 20 615 0.7× 136 0.4× 294 0.9× 438 1.3× 249 1.9× 31 1.5k
P. Roesen Germany 10 379 0.4× 106 0.3× 203 0.6× 148 0.5× 49 0.4× 18 703
Jozef S. Mruk United States 13 348 0.4× 174 0.5× 282 0.8× 200 0.6× 42 0.3× 27 744

Countries citing papers authored by Heather M. Judge

Since Specialization
Citations

This map shows the geographic impact of Heather M. Judge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather M. Judge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather M. Judge more than expected).

Fields of papers citing papers by Heather M. Judge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather M. Judge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather M. Judge. The network helps show where Heather M. Judge may publish in the future.

Co-authorship network of co-authors of Heather M. Judge

This figure shows the co-authorship network connecting the top 25 collaborators of Heather M. Judge. A scholar is included among the top collaborators of Heather M. Judge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather M. Judge. Heather M. Judge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, William A., Dominick J. Angiolillo, Fabiana Rollini, et al.. (2023). Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes. Vascular Pharmacology. 149. 107145–107145. 2 indexed citations
2.
Braza‐Boïls, Aitana, Temo Barwari, Clemens Gutmann, et al.. (2020). Circulating MicroRNA Levels Indicate Platelet and Leukocyte Activation in Endotoxemia Despite Platelet P2Y12 Inhibition. International Journal of Molecular Sciences. 21(8). 2897–2897. 17 indexed citations
3.
Sumaya, Wael, William A. Parker, Heather M. Judge, et al.. (2020). Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention. Platelets. 32(4). 555–559. 5 indexed citations
4.
Parker, William A., et al.. (2018). ULTRA-LOW-DOSE TWICE-DAILY ASPIRIN IMPROVES HEMOSTASIS AND MAINTAINS PLATELET INHIBITION IN ACUTE CORONARY SYNDROME PATIENTS RECEIVING TICAGRELOR. Journal of the American College of Cardiology. 71(11). A30–A30. 1 indexed citations
5.
Judge, Heather M., et al.. (2017). Monitoring Antiplatelet Therapy. Seminars in Thrombosis and Hemostasis. 43(3). 311–319. 24 indexed citations
6.
Storey, Robert F., Dominick J. Angiolillo, Marc P. Bonaca, et al.. (2016). Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial. Journal of the American College of Cardiology. 67(10). 1145–1154. 84 indexed citations
7.
Thomas, Mark R., Ramzi Ajjan, Fladia Phoenix, et al.. (2015). Platelet P2Y 12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model. Arteriosclerosis Thrombosis and Vascular Biology. 35(12). 2562–2570. 100 indexed citations
8.
Judge, Heather M., Lisa K. Jennings, David J. Moliterno, et al.. (2014). PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact. Platelets. 26(3). 236–242. 17 indexed citations
9.
West, Laura, TJ Steiner, Heather M. Judge, Sheila Francis, & Robert F. Storey. (2014). Vessel wall, not platelet, P2Y12 potentiates early atherogenesis. Cardiovascular Research. 102(3). 429–435. 38 indexed citations
10.
Storey, Robert F., Susan S. Smyth, David J. Moliterno, et al.. (2014). Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. Thrombosis and Haemostasis. 112(5). 883–891. 22 indexed citations
11.
12.
Hossain, Rashed, Allison Morton, Rosemary Ecob, et al.. (2013). Evolving pattern of platelet P2Y12inhibition in patients with acute coronary syndromes. Platelets. 25(6). 416–422. 10 indexed citations
13.
Daly, Rebecca, Sonal Mehra, Rosemary Ecob, et al.. (2013). Hirudin anticoagulation allows more rapid determination of P2Y12 inhibition by the VerifyNow P2Y12 assay. Thrombosis and Haemostasis. 109(3). 550–555. 7 indexed citations
14.
Judge, Heather M., Shankar B. Patil, Robert Buckland, Joseph A. Jakubowski, & Robert F. Storey. (2010). Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel. Journal of Thrombosis and Haemostasis. 8(8). 1820–1827. 34 indexed citations
15.
Judge, Heather M., Robert Buckland, Atsuhiro Sugidachi, Joseph A. Jakubowski, & Robert F. Storey. (2008). The active metabolite of prasugrel effectively blocks the platelet P2Y12receptor and inhibits procoagulant and pro-inflammatory platelet responses. Platelets. 19(2). 125–133. 48 indexed citations
16.
17.
18.
19.
Judge, Heather M., Robert A. Wilcox, Stan Heptinstall, & Robert F. Storey. (2002). Inhibition of ADP-induced P-selectin Expression and Platelet-Leukocyte Conjugate Formation by Clopidogrel and the P2Y12 Receptor Antagonist AR-C69931MX but not Aspirin. Thrombosis and Haemostasis. 88(9). 488–494. 121 indexed citations
20.
Heptinstall, S, David Berridge, & Heather M. Judge. (1990). Effects of Streptokinase and Recombinant Tissue Plasminogen Activator on Platelet Aggregation in Whole Blood. Platelets. 1(4). 177–188. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marsha L. Fox Breakdown of academic impact, for papers by Sandra Penz Breakdown of academic impact, for papers by Kenji Misumi Breakdown of academic impact, for papers by DaLi Feng Breakdown of academic impact, for papers by Carmen H. Tong Breakdown of academic impact, for papers by Mariateresa Pugliano Breakdown of academic impact, for papers by Stefania Momi Breakdown of academic impact, for papers by Keiji Takazoe Breakdown of academic impact, for papers by P. Roesen Breakdown of academic impact, for papers by Jozef S. Mruk
Rankless by CCL
2026